RE:No prelim no.s this quarterSince, at this point, the delay in billing after onboarding is obvious, no one should be expecting $6M SaaS revenue in FQ3. Therefore, something less can't be a disappointment, by definition. Of course, logic won't stop emotions...
lscfa wrote: Co's continual boasting of $2 million/month run rate at Dec 31/21 would suggest at least $6 million for Jan /Feb/Mar but that is BS due to 60 to 90 delayed billing. Thus co. can't pre-announce qtr without disappointing.
Oct. 29, 2021 -- Reliq is pleased to provide a preliminary update on Sales for Q1 FY 2022 (quarter ending September 30, 2021). We will file our unaudited quarterly financial statements for the quarter ending September 30, 2021 (Q1 FY 2022) on or before November 29, 2021,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “The preliminary sales figures for Q1 FY 2022 show that revenues have almost tripled, exceeding $1.5 Million total for the quarter."